Inventaire - your friends and communities are your best library

Significance of heparanase in cancer and inflammation

published in: Cancer Microenvironment

date of publication: 2011-08-03

Cites articles 200

Too many entities requested (209). Only 200 are displayed.

Date

Title

Authors

2011-07-11

Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype
2011-04-19

Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors
2011-04-01

Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice
2011-03-29

Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma
2011-06-01

The heparanase system and tumor metastasis: is heparanase the seed and soil?
2011-02-01

PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

Maree Smith
2011-01-25

MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase
2011-01-21

SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis
2011-01-12

Proteolytic networks in cancer
2011-09-01

Pre-clinical and clinical significance of heparanase in Ewing's sarcoma

Giuliana Cassinelli, Cinzia Lanzi
2011-01-11

Activation of heparanase by ultraviolet B irradiation leads to functional loss of basement membrane at the dermal-epidermal junction in human skin
2010-08-31

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting

Nikos K. Karamanos, George Tzanakakis
2010-08-31

Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis
2010-06-01

Tumorigenic and adhesive properties of heparanase
2010-07-07

AACR centennial series: the biology of cancer metastasis: historical perspective
2010-09-03

Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity

Israel Vlodavsky, Flonia Levy-Adam, Neta Ilan, Sari Feld
2010-04-02

Matrix metalloproteinases: regulators of the tumor microenvironment
2010-03-19

Immunity, Inflammation, and Cancer

Michael Karin, Florian Greten
2010-02-25

Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice
2010-04

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

Alberto Mantovani
2010-01-05

The role of heparanase in diseases of the glomeruli

Marian Klinger
2010-01-01

Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats
2010-02-04

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner

Neta Erez, Sarah T Arron
2009-12-01

Tumor self-seeding by circulating cancer cells

Joan Massagué Solé, Larry Norton, Xiang H-F Zhang, Thordur Oskarsson, Swarnali Acharyya
2009-12-09

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics
2009-12-03

Heparin enhances serpin inhibition of the cysteine protease cathepsin L

Piotr S Kowalski, Jens Erik Nielsen
2009-11-30

Cathepsin L, target in cancer treatment?

Anne van der Spek
2009-11-05

Cancer associated fibroblasts in cancer pathogenesis
2009-10-24

Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression

Kieran T Mellody, Akira Orimo
2009-11

STATs in cancer inflammation and immunity: a leading role for STAT3
2009-10-05

Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma

Jürgen Weitz
2009-10-06

Epidemiology of pancreatic cancer: an overview

Sara Raimondi, Patrick Maisonneuve

Article - wd:Q36101233

Welcome to Inventaire

the library of your friends and communities

learn more